# regulations.gov

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/untitled/
> **Published:** 2026-03-18T12:58:08-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:09:13-04:00
> **Clinical Summary:** A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review.

---

## 

A docket-related update affecting [cannabinoid labeling](https://cedclinic.com/cannabinoid-labeling-guidance-updates-digest/), compliance posture, and agency comment review.

Agency: regulations.gov

Document type: Unknown

[Read the source material](https://www.regulations.gov/document/FDA-2026-1002)

{“@context”: “https://schema.org”, “@type”: “GovernmentService”, “name”: “”, “url”: “https://www.regulations.gov/document/FDA-2026-1002”, “about”: “regulations gov”, “provider”: “regulations.gov”}

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).